Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Lujan-Zilbermann

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Genetics|December 3, 2013
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding proteinTravis R Porter, Xuelin Li, Charles B Stephensen, et al.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescentsGeorge K Siberry, Paige L Williams, Jorge Lujan-Zilbermann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trialPeter L Havens, Charles B Stephensen, Rohan Hazra, et al.
Antiviral Therapy|February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumaratePeter L Havens, Rohan Hazra, Charles B Stephensen, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
The New England Journal of Medicine|March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Frontiers in Genetics|December 3, 2013
Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding proteinTravis R Porter, Xuelin Li, Charles B Stephensen, et al.
The Journal of Pediatrics|May 25, 2012
Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virusJorge Lujan-Zilbermann, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|October 12, 2011
Safety and immunogenicity of quadrivalent meningococcal conjugate vaccine in 2- to 10-year-old human immunodeficiency virus-infected childrenGeorge K Siberry, Meredith G Warshaw, Paige L Williams, et al.
The Pediatric Infectious Disease Journal|May 1, 2010
Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescentsGeorge K Siberry, Paige L Williams, Jorge Lujan-Zilbermann, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2012
Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trialPeter L Havens, Charles B Stephensen, Rohan Hazra, et al.
Antiviral Therapy|February 19, 2014
Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumaratePeter L Havens, Rohan Hazra, Charles B Stephensen, et al.
Antimicrobial Agents and Chemotherapy|September 5, 2013
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?Peter L Havens, Jennifer J Kiser, Charles B Stephensen, et al.
The New England Journal of Medicine|March 5, 2015
Valganciclovir for symptomatic congenital cytomegalovirus diseaseDavid W Kimberlin, Penelope M Jester, Pablo J Sánchez, et al.
Pageof 2